EN
HI
Alembic Pharmaceuticals Chart
Alembic Pharmaceuticals Share Key Metrics
Volume
40724.00
Market Cap
14762.87 CR
LTQ@LTP
2@751.05
ATP
757.9
Var Margin
16.34 %
Circuit Range
615-922.5
Delivery %
49.25 %
Value
3.09 CR
ASM/GSM
No
Market Lot
1
Summary
Alembic Pharmaceuticals share price stands at ₹751.05 at 24 Apr, 2026 | 15:59. The stock Alembic Pharmaceuticals intraday movement has stayed between ₹750.00 and ₹781.25, while on a 52-week basis it has fluctuated from ₹635.80 to ₹1107.90.
In terms of trading activity, Alembic Pharmaceuticals has recorded a volume of 40724 shares. The Alembic Pharmaceuticals has a market cap of ₹196563124. The stock’s Average Traded Price (ATP) stands at ₹75790, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2, 75105.
The Alembic Pharmaceuticals operates within a circuit range of ₹615-922.5 – ₹615-922.5, with a Value of ₹3.09 CR. The Delivery Percentage for the day is 49.25%. Additionally, Alembic Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Alembic Pharmaceuticals Fundamentals
View MoreP/E Ratio
23.47
P/B Ratio
2.71
Div. Yield
1.46
Sector P/E
63.82
Sector P/B
3.5
Sec. Div. Yield
0.57
Alembic Pharmaceuticals Resistance and Support
Pivot 771.7
Resistance
First Resistance
781.65
Second Resistance
794.55
Third Resistance
804.5
Support
First Support
758.8
Second Support
748.85
Third Support
735.95
Alembic Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-05 | Quarterly Results |
| 2025-11-04 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-06 | Audited Results & Final Dividend |
| 2025-02-03 | Quarterly Results & Others |
Alembic Pharmaceuticals News
Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Incorporation Of Subsidiary Company
Alembic Pharmaceuticals Limited incorporated Alembic Lifesciences Philippines Inc. in the Philippines. This new subsidiary, with a share capital of Philippine Pesos 12 million, will focus on promoting and distributing pharmaceutical products in the region.
Apr 22 2026 19:04:00
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Alembic Pharmaceuticals received USFDA final approval for Methotrexate Injection USP, 50 mg/2 mL and 1g/40 mL single-dose vials. This approval for the oncology drug enhances the company's US product offerings, adding to its 236 cumulative ANDA approvals.
Apr 16 2026 11:04:00
Read More
About Alembic Pharmaceuticals
NSE : 25328
BSE : 533573
ISIN : INE901L01018
Alembic Pharmaceuticals Management
| Name | Position |
|---|---|
| Chirayu Amin | Chairman & CEO |
| Pranav Amin | Managing Director |
Alembic Pharmaceuticals Similar Stocks
Natco Pharma Ltd.
1093.20
21.75 (2.03%)
Astrazeneca Pharma India Ltd.
8500.00
43.50 (0.51%)
Eris Lifesciences Ltd.
1373.50
-22.20 (1.59%)
Onesource Specialty Pharma Ltd.
1824.30
55.70 (3.15%)
Granules India Ltd.
689.45
2.50 (0.36%)
Poly Medicure Ltd.
1414.20
-73.80 (4.96%)
Jubilant Pharmova Ltd.
945.40
0.05 (0.01%)
Dr. Agarwal's Health Care Ltd.
438.10
-22.45 (4.87%)
Cohance Lifesciences Ltd.
360.10
-3.80 (1.04%)
Caplin Point Laboratories Ltd.
1719.50
-48.50 (2.74%)
Alembic Pharmaceuticals FAQs
The Buying Price of Alembic Pharmaceuticals share is 751.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Alembic Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Alembic Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Alembic Pharmaceuticals shares is 23.47. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Alembic Pharmaceuticals shares is 2.71. Useful to assess the stock's value relative to its book value.
To assess Alembic Pharmaceuticals’s valuation compare Sector P/E, P/B which are 63.82 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Alembic Pharmaceuticals is 14762.87 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Alembic Pharmaceuticals share price is 1107.90 & 635.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Alembic Pharmaceuticals belongs to the Healthcare sector.
